FBO#1626
A - Research and Development
SPECIAL NOTICES - May 10, 2006
- Reference-Number-RQN-1016956 - Synopsis
EPIDEMIOLOGIC STUDIES OF ADVERSE EFFECTS OF MARKETED DRUGS
Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services
- FDA-SOL-06-00208 - Synopsis
ASESSMENT OF VALIDITES OF SELECTED ANALYTICAL PROTOCOLS/PROTOTYPES FOR DIETARY SUPPLEMNETS AND OTHER AREAS OF INTEREST
Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services
- Reference-Number-RQN-1016953 - Synopsis
EPIDEMIOLOGIC STUDIES OF ADVERSE EFFECTS OF MARKETED DRUGS
Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services
- Reference-Number-RQN-1016957 - Synopsis
EPIDEMIOLOGIC STUDIES OF ADVERSE EFFECTS OF MARKETED DRUGS
Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services
- Reference-Number-RQN-1016954 - Synopsis
EPIDEMIOLOGIC STUDIES OF ADVERSE EFFECTS OF MARKETED DRUGS
Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services
| This Issue's Index | Today's FBO Daily Index Page |
Created on 08-May-2006 by Loren Data Corp. -- info@fbodaily.com